| Financier | Commitments |
|---|---|
| IDA Grant | 7.50 |
Liberia COVID-19 Emergency Response Project
Abstract*
The Liberia COVID-19 response project aims to strengthen the Government of Liberia’s immediate capacity to respond to the COVID-19 outbreak and in the longer-term strengthen its capacity to respond to disease outbreaks and emergencies. The project will have fivecomponents: Emergency Preparedness and Response , Laboratory system strengthening, Case management and clinical care , Risk communication, community engagement and advocacy and Project management... Show More
Development Objective
The development objective is to prepare and respond to the COVID-19 pandemic in Liberia
Key Details
Project Details
P173812
Closed
Collins Chansa
Republic of Liberia
March 26, 2020
(as of board presentation)
April 9, 2020
April 13, 2020
US$ 7.50 million
Ministry of Health
2020
US$ 7.50 million
N/A
Substantial
September 30, 2024
No
BANK APPROVED
June 20, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 7.50 |
| IBRD + IDA Commitment | 7.50 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 7.50 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Mar 27, 2023 | IDA-D9000 | Loan Disb | -640,193.10 |
| Jun 9, 2020 | IDA-D6080 | Loan Disb | 151,929.40 |
| May 11, 2020 | IDA-D6080 | Loan Disb | 2,218,774.80 |
| Jun 8, 2020 | IDA-D6080 | Loan Disb | 290,074.00 |
| Sep 18, 2023 | IDA-71990 | Loan Cancel | 1,049,172.80 |
| Sep 18, 2023 | IDA-66090 | Loan Cancel | 318,575.25 |
| Oct 2, 2023 | IDA-71990 | Loan Disb | 223,724.92 |
| Sep 29, 2023 | IDA-66090 | Int Charges | 22,304.28 |
| Sep 29, 2023 | IDA-66090 | Int Charges | 22,304.28 |
| Aug 15, 2024 | IDA-71990 | Int Charges | 6.02 |
| Aug 15, 2024 | IDA-71990 | Int Charges | 6.02 |
| Sep 29, 2023 | IDA-66090 | Int Charges | 429.31 |
| Sep 29, 2023 | IDA-66090 | Int Charges | 429.31 |
| Aug 29, 2024 | IDA-66090 | Int Charges | 22,304.28 |
| Aug 29, 2024 | IDA-66090 | Int Charges | 22,304.28 |
| Aug 29, 2024 | IDA-71990 | Int Charges | 3,816.58 |
| Dec 23, 2022 | IDA-66090 | Loan Disb | 228,624.55 |
| Feb 23, 2023 | IDA-66090 | Int Charges | 20,818.20 |
| Feb 23, 2023 | IDA-66090 | Int Charges | 20,818.20 |
| Aug 15, 2021 | IDA-66090 | Int Charges | 19,568.46 |
| Aug 15, 2021 | IDA-66090 | Int Charges | 19,568.46 |
| Nov 22, 2021 | IDA-66090 | Loan Disb | 192,447.14 |
| Mar 24, 2022 | IDA-66090 | Loan Disb | -175.00 |
| Feb 15, 2022 | IDA-66090 | Int Charges | 20,145.25 |
| Feb 15, 2022 | IDA-66090 | Int Charges | 20,145.25 |
| Aug 15, 2022 | IDA-66090 | Int Charges | 20,818.45 |
| Aug 15, 2022 | IDA-66090 | Int Charges | 20,818.45 |
| May 11, 2020 | IDA-66090 | Loan Disb | 2,218,774.80 |
| Jun 8, 2020 | IDA-66090 | Loan Disb | 290,074.00 |
| Jun 9, 2020 | IDA-66090 | Loan Disb | 151,929.40 |
| Dec 7, 2020 | IDA-66090 | Loan Disb | 349,750.00 |
| Feb 15, 2021 | IDA-66090 | Int Charges | 18,153.90 |
| Feb 15, 2021 | IDA-66090 | Int Charges | 18,153.90 |
| Aug 15, 2020 | IDA-66090 | Int Charges | 8,595.43 |
| Aug 15, 2020 | IDA-66090 | Int Charges | 8,595.43 |
| Aug 29, 2024 | IDA-71990 | Int Charges | 3,816.58 |
| Aug 22, 2024 | IDA-71990 | Loan Disb | 53,178.31 |
| Apr 4, 2024 | IDA-71990 | Loan Disb | 278,792.94 |
| Mar 5, 2024 | IDA-71990 | Int Charges | 628.07 |
| Mar 5, 2024 | IDA-71990 | Int Charges | 628.07 |
| Jun 5, 2024 | IDA-71990 | Loan Disb | 124,000.00 |
| Apr 1, 2024 | IDA-66090 | Int Charges | 22,304.28 |
| Apr 1, 2024 | IDA-66090 | Int Charges | 22,304.28 |
| Apr 8, 2024 | IDA-71990 | Loan Disb | 121,706.32 |
| Apr 8, 2024 | IDA-71990 | Loan Disb | 655,436.20 |
| Dec 7, 2020 | IDA-D6080 | Loan Disb | 349,750.00 |
| Apr 9, 2020 | IDA-66090 | Loan Commitment | 3,750,000.00 |
| Apr 9, 2020 | IDA-D6080 | Loan Commitment | 3,750,000.00 |
| Jun 30, 2021 | IDA-D9000 | Loan Commitment | 7,000,000.00 |
| Jun 30, 2022 | IDA-E1140 | Loan Commitment | 6,200,000.00 |
| Jun 30, 2022 | IDA-71990 | Loan Commitment | 2,800,000.00 |
| Sep 18, 2023 | IDA-E1140 | Loan Cancel | 2,298,188.20 |
| Sep 18, 2023 | IDA-D6080 | Loan Cancel | 340,874.06 |
| Sep 18, 2023 | IDA-D9000 | Loan Cancel | 1,994,180.50 |
| Apr 9, 2024 | IDA-E1140 | Loan Disb | 270,894.72 |
| Mar 28, 2024 | IDA-E1140 | Loan Disb | 620,539.06 |
| Apr 8, 2024 | IDA-E1140 | Loan Disb | 1,458,874.10 |
| Aug 23, 2024 | IDA-E1140 | Loan Disb | 118,364.62 |
| Jul 10, 2024 | IDA-E1140 | Loan Disb | 276,000.00 |
| Mar 24, 2022 | IDA-D6080 | Loan Disb | -175.00 |
| Nov 22, 2021 | IDA-D6080 | Loan Disb | 192,447.16 |
| Mar 14, 2022 | IDA-D9000 | Loan Disb | 745,200.00 |
| Jan 10, 2022 | IDA-D9000 | Loan Disb | 579,678.00 |
| Aug 4, 2022 | IDA-D9000 | Loan Disb | 1,092,206.00 |
| Mar 9, 2022 | IDA-D9000 | Loan Disb | 2,027,184.80 |
| Dec 23, 2022 | IDA-D6080 | Loan Disb | 228,624.56 |
| Aug 1, 2022 | IDA-D9000 | Loan Disb | 645,697.00 |
| Oct 24, 2022 | IDA-D9000 | Loan Disb | -5,503.85 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2025-01-22 |
| Monitoring and Evaluation | Satisfactory | 2025-01-22 |
| Financial Management | Moderately Unsatisfactory | 2025-01-22 |
| Project Management | Moderately Satisfactory | 2025-01-22 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2025-01-22 |
| Procurement | Moderately Satisfactory | 2025-01-22 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Country has activated its Public Health Emergency Operations Center or a coordination mechanism for COVID-19 Value No Yes Yes Date June 30, 2022 June 21, 2023 September 30, 2024 Comment Suspected cases of COVID-19 reported and investigated based on national guidelines, segregated by gender Value 3.00 8090.00 8000.00 Date March 31, 2020 May 13, 2024 September 30, 2024 Comment Suspected cases of COVID-19 in women reported and investigated based on national guidelines Value 0.00 2580.00 0.00 Date Comment Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents Value 1.00 4.00 3.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Acute health care facilities with isolation capacities Value 2.00 7.00 6.00 Date March 31, 2020 May 13, 2024 September 30, 2024 Comment Counties with pandemic preparedness and response plans per MOH guidelines Value 0.00 100.00 100.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Facilities with healthcare workers trained in COVID-19 emergency preparedness and other emergency response Value 0.00 80.00 80.00 Date March 31, 2020 May 13, 2024 September 30, 2024 Comment Facilities with female healthcare workers trained in COVID-19 emergency preparedness and other emergency response Value 0.00 60.00 0.00 Date Comment Country has developed and operationalized a referral system to care for COVID-19 patients Value No Yes Yes Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Population completely vaccinated against COVID-19 Value 1.00 86.00 65.60 Date June 1, 2021 May 13, 2024 September 30, 2024 Comment Population completely vaccinated who are women Value 40.00 46.00 0.00 Date Comment Population between 12 to 17 years of age completely vaccinated Value 0.00 0.00 0.00 Date Comment Population over 60 years completely vaccinated Value 0.00 0.00 0.00 Date Comment Population that have received at least one booster shot in addition to the complete initial protocol Value 0.00 0.30 15.00 Date January 1, 2022 June 21, 2023 September 30, 2024 Comment Female population that have received at least one booster shot in addition to the complete initial protocol (Percentage) Value 0.00 0.00 0.00 Date Comment Counties with at least two facilities providing COVID-19 vaccination services Value 0.00 100.00 100.00 Date June 15, 2021 June 21, 2023 September 30, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Point of entry that report having received a supervisory visit during the preceding month Value 0.00 80.00 80.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Counties that have activated EOC inline with the national EOC activation as part of COVID-19 response Value 0.00 100.00 80.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Prioritized facilities reporting supervisory visits on the first day of each month Value 0.00 6.00 5.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment At least one multi-sectoral simulation exercise conducted with results incorporated into national COVID-19 preparedness and response plans Value 1.00 2.00 3.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment EOC organized as part of COVID-19 response Value 0.00 16.00 20.00 Date March 31, 2020 May 13, 2024 September 30, 2024 Comment Counties with EOCs functioning according to standard operating procedures Value 0.00 100.00 80.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Refurbished/upgraded health facilities implementing customer satisfaction survey Value 0.00 0.00 5.00 Date April 14, 2020 June 21, 2023 September 30, 2024 Comment COVID-19 vaccine doses procured Value 0.00 381600.00 300000.00 Date June 1, 2021 June 21, 2023 September 30, 2024 Comment Counties with budgeted micro-plans for COVID-19 vaccination campaign Value 0.00 15.00 15.00 Date June 1, 2021 June 21, 2023 September 30, 2024 Comment National, subnational, facility-based and mobile staff trained in COVID-19 vaccine cold chain storage and handling (by gender) Value 0.00 1353.00 1000.00 Date June 1, 2021 June 21, 2023 September 30, 2024 Comment Training of Project Implementation Unit (PIU) staff Value 0.00 15.00 10.00 Date June 1, 2021 June 21, 2023 September 30, 2024 Comment National, subnational, facility-based and mobile female staff trained in COVID-19 vaccine cold chain storage and handling Value 0.00 135.00 0.00 Date Comment Grievances addressed within the stipulated timeframe Value 0.00 100.00 100.00 Date June 30, 2021 May 13, 2024 September 30, 2024 Comment Facilities equipped (installation complete) with energy-efficient storage facilities for storing specimens and temperature sensitive medical supplies Value 0.00 72.00 50.00 Date June 1, 2021 June 21, 2023 September 30, 2024 Comment Pharmacovigilance system adapted to detect AEFI following administration of the COVID-19 vaccine Value No Yes Yes Date June 1, 2021 June 21, 2023 September 30, 2024 Comment AEFIs reported via the electronic notification system Value 0.00 100.00 100.00 Date June 1, 2021 June 21, 2023 September 30, 2024 Comment Community engagement plan developed to increase the population's demand for the COVID-19 vaccine Value No Yes Yes Date June 1, 2021 June 21, 2023 September 30, 2024 Comment Counties where radio stations broadcast awareness campaigns on COVID-19 and the COVID-19 vaccination campaign Value 0.00 15.00 15.00 Date June 1, 2021 June 21, 2023 September 30, 2024 Comment Vaccinators trained on SEA/SH (by gender) Value 0.00 393.00 1000.00 Date June 1, 2021 May 13, 2024 September 30, 2024 Comment Female vaccinators trained on SEA/SH Value 0.00 0.00 0.00 Date Comment Health centers reporting no stock-out of tracer IPC materials on the first day of each month Value 0.00 43.00 50.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Laboratories established/upgraded to support diagnosis of COVID-19 and other major infectious diseases Value 1.00 7.00 3.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment Laboratory staff trained to conduct COVID-19 diagnosis Value 2.00 20.00 10.00 Date March 31, 2020 June 21, 2023 September 30, 2024 Comment